Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial

BACKGROUND: Whether they are injected peri- or intraocularly, corticosteroids are still essential tools in the therapeutic arsenal for treating inflammatory macular oedema. A few years ago, however, only triamcinolone acetonide was available to ophthalmologists. While this compound was initially dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Couret, Chloé, Poinas, Alexandra, Volteau, Christelle, Riche, Valery-Pierre, Le Lez, Marie-Laure, Errera, Marie-Hélène, Creuzot-Garcher, Catherine, Baillif, Stéphanie, Kodjikian, Laurent, Ivan, Catherine, Le Jumeau de Kergaradec, Laurence Mathilde, Chiffoleau, Anne, Jobert, Alexandra, Jaulin, Julie, Biron, Laetitia, Hervouet, Elisabeth, Weber, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011383/
https://www.ncbi.nlm.nih.gov/pubmed/32041669
http://dx.doi.org/10.1186/s13063-020-4066-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011383/
https://www.ncbi.nlm.nih.gov/pubmed/32041669
http://dx.doi.org/10.1186/s13063-020-4066-0

Ejemplares similares